Search Results
209 results
Your search is now limited to «AstraZeneca» expert search.
WN.com 03/21/2019 11:56
Pharmaceutical giant AstraZeneca is forecast to post some impressive advances in earnings.
More from WN.com:
Zacks.com 03/21/2019 08:11
Today's Research Daily features new research reports on 16 major stocks, including Las Vegas Sands, Phillips 66 and AstraZeneca.
More from Zacks.com:
(MENAFN - EIN) Highly Potent Active Pharmaceutical Ingredients Conference 2019 Highly Potential Active Pharmaceutical Ingredients Conference 2019 LONDON, UNITED KINGDOM, March 21...
More from Middle East North Africa Financial Network (MENAFN):
GlobeNewswire 03/20/2019 02:00
This amount corresponds to the $50 million initial payment (€43.5 million) paid to AstraZeneca in January 2019, reduced by $15.0 million (€13 million), which corresponds to the maximum amount to be financed by AZ for commercial and R&D costs for the fiscal year 2019 (cost sharing mechanism.
More from GlobeNewswire:
Pharmafile 03/19/2019 07:25
AZ's Farxiga reduces major adverse cardiovascular event risk in type 2 diabetes, new data shows.
More from Pharmafile:
pharmaphorum 03/19/2019 06:46
AstraZeneca continues to make the case for its Farxiga diabetes drug, highlighting a cardiology analysis that it hopes will convince more doctors to prescribe it in a highly competitive market.
More from pharmaphorum:
PharmaTimes 03/18/2019 16:04
Trial data show that AstraZeneca’s Farxiga (dapagliflozin) cut the relative risk of major adverse cardiovascular events (MACE) by 16% compared to placebo in patients with type II diabetes who had a prior heart attack.
More from PharmaTimes:
BioPharma Dive 03/18/2019 09:33
Dive Brief: The cardiovascular benefits of AstraZeneca's Type 2 diabetes drug Farxiga appear more pronounced in patients with heart failure and a condition known as reduced ejection fraction, new findings reported Monday at the American College of Cardiology's annual meeting suggest.
More from BioPharma Dive:
FiercePharmaManufacturing 03/18/2019 08:03
Rod Wooten, AstraZeneca VP of Cardiovascular and Metabolic Diseases, told FiercePharma that the FDA has accepted its application for the label tweak, and AZ hopes for an approval in the fourth quarter.
More from FiercePharmaManufacturing:
Market Exclusive 03/18/2019 07:19
The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999.
More from Market Exclusive:
ENDPOINTS 03/15/2019 10:51
France’s Innate Pharma has wooed AstraZeneca vet Jennifer Butler to lead the US operations it has set up after acquiring Lumoxiti from the British drugmaker in a rich add-on collaboration deal.
More from ENDPOINTS:
FierceBiotech 03/14/2019 09:58
AstraZeneca taps microbiome specialist Seres for I-O support AstraZeneca has teamed up with Seres Therapeutics to explore whether microbiome therapeutics can increase the efficacy of cancer immunotherapies.
More from FierceBiotech:
PMLiVE 03/14/2019 08:56
AstraZeneca is expected to share some oncology pipeline developments towards the end of the month, providing updates on two of its biggest selling cancer assets Tagrisso and Imfinzi.
More from PMLiVE:
In addition, the company’s investigational microbiome therapeutic SER-401 could be evaluated in combination with AstraZeneca compounds targeting multiple cancers, as part of the collaboration.
More from Pharmaceutical Business Review:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications